BioPharmSignal logoBioPharmSignal

Biotech News

PTC Therapeutics to Participate at Upcoming Investor Conferences

PTC Therapeutics, Inc. (PTCT)PTC Therapeutics, Inc.Conference / presentation

WARREN, N.J., Feb. 23, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that its executives will speak at the following conferences: TD Cowen 46th Annual Health Care Conference 2026 Monday, March 2 at 9:50 a.m. ET Leerink 2026 Global Healthcare Conference Tuesday,

Open original release

Related news

PTCTPTC Therapeutics, Inc.2026-05-04 12:00 EST

PTC Therapeutics to Participate in Upcoming Investor Conferences

PTCTPTC Therapeutics, Inc.2026-04-28 13:28 EST

PTC Therapeutics to Report Results from PIVOT-HD Long Term Extension Study

APLSApellis Pharmaceuticals2025-11-25 12:00 EST

Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences

BCRXBioCryst Pharmaceuticals2026-04-28 11:00 EST

BioCryst to Present at Upcoming Investor Conferences

ARWRArrowhead Pharmaceuticals2026-06-02 11:30 EST

Arrowhead Pharmaceuticals to Participate in Upcoming June 2026 Events

ARWRArrowhead Pharmaceuticals2026-05-04 11:30 EST

Arrowhead Pharmaceuticals to Participate in Upcoming May 2026 Events

BCRXBioCryst Pharmaceuticals2026-02-17 12:00 EST

BioCryst to Present at Upcoming Investor Conference

CRNXCrinetics Pharmaceuticals2026-05-22 20:05 EST

Crinetics Pharmaceuticals to Participate in Jefferies Global Healthcare Conference 2026

TARAProtara Therapeutics2026-01-07 13:00 EST

Protara Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

RCKTRocket Pharmaceuticals2026-01-05 12:00 EST

Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference

View all latest news

PTC Therapeutics, Inc.

PTC Therapeutics is a biopharmaceutical company focused on rare disease and gene-related therapies. Its story combines commercial products with a pipeline aimed at genetically defined conditions.

Recent company news

PTCTPTC Therapeutics, Inc.2026-05-07 20:01 EST

PTC Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results

PTCTPTC Therapeutics, Inc.2026-05-04 12:00 EST

PTC Therapeutics to Participate in Upcoming Investor Conferences

PTCTPTC Therapeutics, Inc.2026-04-28 20:05 EST

PTC Therapeutics Reports Positive Topline Results from Month 24 Interim Analysis of PIVOT-HD Extension Study of Votoplam

PTCTPTC Therapeutics, Inc.2026-04-28 13:28 EST

PTC Therapeutics to Report Results from PIVOT-HD Long Term Extension Study

PTCTPTC Therapeutics, Inc.2026-04-22 12:00 EST

PTC Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026

Stock data

Close
75.80 USD
Market cap
5.66B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States